Positive interim efficacy data in 2025 underscore potential of ETX101 as a one-time, disease-modifying medicine for Dravet syndrome –– Internal GMP manufacturing capable of supporting pivotal trial ...
Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have uncovered previously unobserved oscillation ...
Addressing the core issues of latency and integration in developing audio amplifiers for today’s smart cockpits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback